Investigadores de la U742 CIBERER que lidera Pascual Sanz en el Instituto de Biomedicina de Valencia (CSIC) han desarrollado un estudio preclínico que confirma que los moduladores de la transmisión ...
Read moreUn equipo de investigación de la Universitat Politècnica de València (UPV), perteneciente al Instituto de Automática e Informática Industrial, trabaja en el desarrollo de una bomba de insulina co...
Read moreSeveral technologies are available in healthcare industry to facilitate our job in identifying results accurately. And the competition between providers is identically healthy to us as this is vital b...
Read moreEl informe del experto independiente Antonio Oliviero destaca el “alto perfil de seguridad” del fármaco y que “el 50% de los pacientes incluidos en el ensayo respondió positivamente al trat...
Read moreUn estudio liderado desde el Centro de Biología Molecular Severo Ochoa, centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad Autónoma de Madrid (UAM), y en colab...
Read moreThe research also opens the door to new neurotransmitter modulating drugs that could be effective treatments
Read moreResearchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the ...
Read moreThe study, led by researchers from Hospital Clínic-IDIBAPS, analyzes the genetic variants associated with the risk of developing the cancer and should make it possible to reduce the number of unneces...
Read moreAn international study involving the IBB-UAB has identified how the 20 different forms of the p53 protein, unique to elephants, are activated to increase sensitivity and response against carcinogenic ...
Read moreLa combinación de inteligencia artificial y tecnologías de aprendizaje automático permite augurar un futuro con diagnósticos más fiables y personalizados para tratar con mayor eficacia enfermedad...
Read moreFoundation for Addie’s Research Joins Oncoheroes moving volasertib into a clinical trial to create more and better options for children fighting cancer.
Read moreVall d’Hebron Research Institute (VHIR), a world-leading healthcare institution where healthcare, research, innovation and education go hand in hand, and Oncoheroes Biosciences, a biotech company ex...
Read more